Close

Press Releases

ReciBioPharm secures a significant grant to advance RNA manufacturing

3-year grant received from the Bill & Melinda Gates Foundation to enhance RNA production technologies Grant enables global implementation of the RNA Continuous Manufacturing platform and advancement of Process Analytical Technologies (PAT), developed through an MIT project funded...

Swiss Airtainer reaches major milestone with successful completion of first 50 commercial shipments

Swiss Airtainer is pleased to announce the successful completion of its first 50 commercial shipments of high-value life science products. These shipments have demonstrated the performance, sustainability, and cost-efficiency of Swiss Airtainer’s RKN temperature-controlled containers in real-world operations and marks a significant achievement in the company’s mission to provide the pharmaceutical industry with sustainable and...

Astorg Continues to Bolster its Newly Combined Global Leader in Assisted Reproductive Technology by Acquiring FUJIFILM Irvine Scientific’s Medical Media Business

Luxembourg / London / New York / Boston / Paris – Following Astorg’s recent take-private of Hamilton Thorne, and simultaneous acquisition of Cook Medical’s Reproductive Health business (“Cook Medical RH”), the newly combined global leader in assisted reproductive technology...

GELITA launches Endotoxin Controlled Excipients for bioscience applications

New portfolio comprises innovative collagen solutions for parenteral applications, medical devices and 3D bioprinting GELITA, a leading manufacturer of collagen and gelatin, proudly announces the launch of its Endotoxin Controlled Excipients (ECE) portfolio. This cutting-edge product line, featuring VACCIPRO® and MEDELLAPRO®, meets the stringent demands of...

Key steps to bring ADCs successfully to clinical trial

The use of antibody-drug-conjugates (ADC) in drug development is becoming more and more widespread, thanks to their potential to improve the effectiveness of cancer treatments by enabling more precise targeting of cancerogenic cells. ADCs harness a mechanism based on...

Zydus announces USFDA Orphan Drug Designation to Usnoflast for the treatment of Amyotrophic Lateral Sclerosis (ALS)

Zydus, a leading, discovery-based, global pharmaceutical company today announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic lateral sclerosis (ALS). The USFDA's Office of Orphan Drug...

Pharmapack Europe the ‘Heart of Pharma’ Start-ups in Paris

Live from Porte De Versailles, Paris: Pharmapack Europe 2025 (January 22–23) selects six start-ups from its 26 strong field of innovators to receive the Pharmapack Europe ‘heart of pharma’. A special commendation given to these early-stage companies advancing new breakthrough...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read